Stay updated on Parpvax: Niraparib + Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Parpvax: Niraparib + Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Parpvax: Niraparib + Immunotherapy Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The completed PARPVAX pancreatic cancer trial record is displayed, with its eligibility criteria, treatment arms, outcome measures, collaborators, study dates, and linked study documents.
    Difference
    52%
    Check dated 2026-11-08T06:17:57.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T04:14:44.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website updates and says NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T06:23:35.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T04:46:19.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T08:22:40.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content, signaling an access restriction to the study record on ClinicalTrials.gov.
    Difference
    19%
    Check dated 2026-09-20T03:19:41.000Z thumbnail image

Stay in the know with updates to Parpvax: Niraparib + Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Parpvax: Niraparib + Immunotherapy Clinical Trial page.